Physician profile
Melanie B Helmken
NPI 1114964152
$3,326.23
in general payments reported to CMS, 2019-2025
32 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,020 · 2020: $363 · 2021: $990 · 2022: $954.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $623.24 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $248.06 | 2019-2022 | |
| Therapeuticsmd, INC. | $243.15 | 2019-2022 | |
| Aspira Women'S Health INC | $226.14 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $180.06 | 2021-2022 | |
| Amag Pharmaceuticals, INC. | $172.85 | 2019 | |
| Allergan, INC. | $165.82 | 2019-2020 | |
| Myovant Sciences INC. | $149.40 | 2021-2022 | |
| Scynexis, INC. | $132.17 | 2022 | |
| Exeltis, USA INC. | $119.01 | 2021-2022 | |
| Astellas Pharma US INC | $112.14 | 2019-2020 | |
| Evofem Biosciences, INC. | $111.83 | 2020-2022 | |
| Mylan Pharmaceuticals INC. | $100.70 | 2021-2022 | |
| Hologic Sales and Service, LLC | $98.72 | 2019-2022 | |
| Lupin INC. | $82.20 | 2019-2021 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $74.97 | 2019-2020 | |
| Amgen INC. | $73.27 | 2019-2021 | |
| Agile Therapeutics, INC. | $61.76 | 2021-2022 | |
| Channel Medsystems, INC. | $58.42 | 2022 | |
| Duchesnay USA Incorporated | $48.61 | 2019 | |
| Avion Pharmaceuticals | $37.99 | 2019-2021 | |
| Pfizer INC. | $36.04 | 2022 | |
| Millicent US INC | $31.39 | 2019-2021 | |
| Roche Diagnostics Corporation | $24.71 | 2019 | |
| Radius Health, INC. | $21.36 | 2019 | |
| Ascend Therapeutics US, LLC | $18.00 | 2021 | |
| Organon LLC | $14.81 | 2022 | |
| Merck Sharp & Dohme LLC | $12.90 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $12.17 | 2019 | |
| Mission Pharmacal Company | $11.82 | 2019 | |
| Glaxosmithkline, LLC. | $11.73 | 2019 | |
| Minerva Surgical, INC | $10.79 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melanie Helmken listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.